NovoLog Mix 70/30

insulin aspart protamine and insulin aspart mix 70/30 · Novo Nordisk Pharma, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for NovoLog Mix 70/30, covering 2013-03-09 to 2017-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes [Phase 3]

See pricing